In this study, it was observed that the treatment of human neuroblastoma cells (SH-SY5Y) with 20 μM of 6-OHDA resulted in a significant decrease in cell viability and an evident rise in caspase 3 activity. This evidence concerns the gene CASP3 and neuroblastoma.